A carregar...

A Novel MYH9-RET Fusion Occurrence and EGFR T790M Loss as an Acquired Resistance Mechanism to Osimertinib in a Patient with Lung Adenocarcinoma: A Case Report

Yanwei Sun,1 Lina Pei,2 Ningning Luo,3 Dongsheng Chen,3 Lingxin Meng1 1Department of Oncology, People’s Hospital of Rizhao, Rizhao, People’s Republic of China; 2Department of Pharmacy, People’s Hospital of Rizhao, Rizhao, People’s Republic of China; 3The State...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Sun Y, Pei L, Luo N, Chen D, Meng L
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2020-11-01
Colecção:OncoTargets and Therapy
Assuntos:
Acesso em linha:https://www.dovepress.com/a-novel-myh9-ret-fusion-occurrence-and-egfr-t790m-loss-as-an-acquired--peer-reviewed-article-OTT
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!